The first-ever eye drop approved by the U.S. Food and Drug Administration to combat symptoms of presbyopia, or age-related blurry near vision, is now available by prescription nationwide. Pharmaceutical company Allergan, owned by AbbVie, announced the development on Dec. 9. The company says its eye drops, “Vuity,” or pilocarpine hydrochloride ophthalmic solution 1.25 percent, is now the only FDA-approved eye drop to manage presbyopia symptoms. The FDA approved Vuity on Oct. 28. Presbyopia is an age-related progressive condition that typically starts around age 40. In presbyopia, the lens behind the iris becomes progressively less able to change shape, which affects the eyes’ ability to focus on closer objects. The pilocarpine hydrochloride combats symptoms of presbyopia by improving vision at near and intermediate distances, without impacting distance vision, Allergan said in its release. The drop is intended to be taken daily and is expected to take effect within 15 minutes and last up to six …